Portal de Periódicos da CAPES

A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example

2009; Public Library of Science; Volume: 6; Issue: 12 Linguagem: Inglês

10.1371/journal.pmed.1000194

1549-1676

Tjeerd van Staa, Hubert G. M. Leufkens, Bill Zhang, Liam Smeeth,

Health Systems, Economic Evaluations, Quality of Life

Tjeerd-Pieter van Staa and colleagues estimate the likely cost effectiveness of selective Cox-2 inhibitors prescribed during routine clinical practice, as compared to the cost effectiveness predicted from randomized controlled trial data.